Advatech begins trial of device for treatment of chronic wounds

By Angela McDaniels

Seattle, Feb. 9 - Advatech Corp. said it has begun a clinical trial of its Field Therapy Accelerator device for the treatment of severe, chronic wounds.

Participants will receive four one-hour treatments per week for a period of six weeks. Measurement of wound size and appearance will be used to determine the effect of the treatment.

Results are expected in mid spring.

Advatech said that additional trials are planned to test the device's ability to increase healing rates after MOHS surgery, an advanced treatment procedure for skin cancer, and to activate changes in genetic regulation that are diagnostic precursors of chronic wound healing.

"The treatment of chronic wounds is a $3 billion per year business," Michael Spiegel, director of science and product development, said in a company news release.

Advatech is an early stage medical device development company based in Miami that researches and develops products for non-invasive therapeutic medicine.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.